Prime Medicine, Inc. (PRME)
3.595
-0.02
(-0.42%)
USD |
NASDAQ |
Aug 31, 16:00
3.595
0.00 (0.00%)
After-Hours: 20:00
Prime Medicine Cash from Operations (Annual) : -162.56M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -162.56M |
| December 31, 2024 | -122.86M |
| December 31, 2023 | -165.41M |
| December 31, 2022 | -131.83M |
| Date | Value |
|---|---|
| December 31, 2021 | -34.08M |
| December 31, 2020 | -5.544M |
| December 31, 2019 | -1.334M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Beam Therapeutics, Inc. | -345.10M |
| Twist Bioscience Corp. | -47.63M |
| Sana Biotechnology, Inc. | -143.83M |
| Intellia Therapeutics, Inc. | -394.74M |
| Revolution Medicines, Inc. | -897.74M |